Netanyahu’s Likud claims Israel election was stolen despite 53-seat result as officials reject fraud allegations
Cambrex begins $120m Iowa API expansion, but can new peptide capacity deliver commercial returns by 2028?
Read More Pharma Industry News Azenta (AZTA) expands GENEWIZ with SynPlexity acquisition and $71m potential Elegen commitment Azenta, Inc. (NASDAQ: AZTA) has acquired synthetic biology specialist SynPlexity Inc. and entered an exclusive technology licensing arrangement… byPallavi MadhirajuOctober 30, 2026